drugset / Trial / NCT01645098

Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy

NCT01645098 ↗

Completed 53 enrolled Nationwide Children's Hospital
Non-randomizedCrossoverOpen-labelTreatment

Summary

This is an interventional study on Duchenne muscular dystrophy patients who will be receiving sedation for a muscle biopsy as part of another study.

Timeline

Start
2011-08
Primary completion
2013-04
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Background Ketamine Small molecule 1 mg/kg Intravenous